作者: Eric Jacob Watsky , Edmund Patrick Harrigan , Brian Thomas O'neill , Jotham Wadsworth Coe , Steven Bradley Sands
DOI:
关键词:
摘要: A pharmaceutical composition and method of treatment diseases cognitive dysfunction in a mammal comprising administration nicotine receptor partial agonist or pharmaceutically acceptable salt thereof; an acetylcholinesterase inhibitor, butylcholinesterase estrogenic agent, selective estrogen modulator muscarinic carrier. The estrogen, are present amounts that render the effective enhancing cognition including but not limited to Alzheimer's Disease, mild impairment, age-related decline, vascular dementia, Parkinson's disease Huntington's Stroke, TBI, AIDS associated dementia schizophrenia. using these compositions is also disclosed.